Cargando…
Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts
OBJECTIVES: To assess predictive factors for rheumatoid arthritis interstitial lung disease (RA-ILD) in two early rheumatoid arthritis (RA) inception cohorts with a focus on methotrexate (MTX) exposure. DESIGN: Multicentre prospective early RA inception cohort studies; the early RA study (ERAS) and...
Autores principales: | Kiely, Patrick, Busby, A D, Nikiphorou, E, Sullivan, K, Walsh, D A, Creamer, P, Dixey, J, Young, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501950/ https://www.ncbi.nlm.nih.gov/pubmed/31061059 http://dx.doi.org/10.1136/bmjopen-2018-028466 |
Ejemplares similares
-
Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort
por: McWilliams, Daniel F, et al.
Publicado: (2013) -
Safety Profile of Methotrexate Therapy in Patients With Rheumatoid Arthritis
por: Mustafa, Syed Hassan, et al.
Publicado: (2022) -
Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort
por: McWilliams, Daniel F., et al.
Publicado: (2014) -
Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network
por: Nikiphorou, Elena, et al.
Publicado: (2020) -
Using thoracic ultrasound to detect interstitial lung disease in patients with rheumatoid arthritis: a protocol for the diagnostic test accuracy AURORA study
por: Sofíudóttir, Bjørk Khaliqi, et al.
Publicado: (2022)